{
    "title": "Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10439323/Pfizer-BioNTech-launch-trial-Omicron-targeted-COVID-vaccine.html",
    "date": "2022-01-25",
    "keywords": [
        "vaccine",
        "omicron",
        "protection",
        "dose",
        "variant",
        "trial",
        "booster",
        "pfizerbiontech",
        "research",
        "level",
        "disease",
        "hospitalization",
        "infection",
        "york",
        "jan",
        "se",
        "tuesday",
        "version",
        "covid19",
        "response",
        "regimen",
        "shot",
        "safety",
        "tolerability",
        "realworld",
        "need",
        "event",
        "time",
        "address",
        "future",
        "development",
        "kathrin",
        "jansen",
        "statement",
        "pfizer",
        "control",
        "prevention",
        "study",
        "httpswwwreuterscomworldmiddleeastisraelistudyshows4thshotcovid19vaccinenotableblockomicron20220117",
        "israel",
        "mrna",
        "reporting",
        "erman",
        "adler"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}